The 27 references in paper S. Ponomarenko V., С. Пономаренко В. (2018) “Экономические барьеры, тормозящие производство терапевтического рекомбинантного трипсина человека. Применение инновационных технологий для их преодоления // Economic barriers restraining the production of therapeutic recombinant human trypsin. Use of innovative technologies to overcome them” / spz:neicon:pharmacoeconomics:y:2018:i:3:p:58-66

1
UniProtKB – P07477 (TRY1_HUMAN). [electronic resource]. URL: https://www.uniprot.org/uniprot/P07477/. Accessed: 08.07.2018.
(check this in PDF content)
2
Vandermarliere e., Mueller M., Martens L. Getting intimate with trypsin, the leading protease in proteomics. Mass Spectrometry Reviews. 2013; 32: 453-465.
(check this in PDF content)
3
Gaboriaud C., Serre L., Guy-Crotte O., Forest e., FontecillaCamps J. S. Crystal structure of human trypsin 1: unexpected phosphorylation of Tyr151. J. Mol. Biol. 1996; 259 (5): 995-1010. DOI: 10.1006/jmbi.1996.0376.
(check this in PDF content)
4
Rypniewski W., Pirrakis A., Vorgias C. e., Wilson K. S. evolutionary Devergence and Concervation of Trypsin. Protein engineering. 1994; 7 (1): 57-64.
(check this in PDF content)
5
Patent RU (11) 2 265 053 (13) C2 IPC C 12 N 9/76. The method of obtaining trypsin. Albulov AI, Samuylenko A. Ya., Fomenko A. S. and others. The patent holder is VNITIBP. Application: 2002134730/13, December 24, 2002. Published on: 27.11.2005. Bul. N 33. [Patent RU(11) 2 265 053(13) C2 MPk C 12 N 9/76. Sposob polucheniya tripsina. Albulov A. I., Samuylenko A.YA., Fomenko A. S. et al. Patentoobladatel’ – VNITIBP. Zayavka: 2002134730/13, 24.12.2002. opublikovano: 27.11.2005. Byul. N 33 (in Russian)].
(check this in PDF content)
6
Kislitsin Yu.A., Rebrikov D. V., Dunaevskiy Ya.e., Rudenskaya G. N. Bioorganicheskaya himiya (in Russian). 2003; 29 (3): 269-276.
(check this in PDF content)
7
Brodrick J. W., Largman C., Johnson J. H., Geokas M. C. Human Cation Trypsinogen Purification, Characterization, and Characteristic of Autoactivation. J. Biol. Chem. 1978; 253 (8): 2732-2736.
(check this in PDF content)
8
Iannucci N. B., Albanesi G. J., Marani M. M., Fernández H.M. Isolation of Trypsin from Bovine Pancreas Using Immobilized Benzamidine and Peptide CTPR Ligands in expanded Beds. Separat. Sci. Techn. 2005; 40: 3277-3287. DOI: 10.1080/01496390500423631.
(check this in PDF content)
9
Goudarzi B. Gh., Talebi M., Bagherian R., Haji Hosseini R. A simple, fast and commercial method for trypsin purification from bovine pancreas. Vet. Res. Biol. Prod. 2011; 24 (1-90): 33-39.
(check this in PDF content)
10
Buettner K., Kreisig T., Sträter N., Zuchner T. Protein surface charge of trypsinogen changes its activation pattern. BMC Biotechnology. 2014; 14 (960): 1-11. DOI: 10.1186/s12896-014-0109-5. roche/ RTRYPRO?lang=de®ion=De RTRYP-RO Roche. Accessed: 09.07.2018. 28. Trypsin recombinant Pig. [electronic resource]. URL: https:// www.mybiosource.com/prods/Recombinant-Protein/Trypsin/ RYP/ datasheet.php?products_id=9422455. Accessed: 09.07.2018. 29. Trypsin Powder, Porcine 1:250. [electronic resource]. URL: https://www.sigmaaldrich.com/catalog/product/sigma/85450c?lang= de®ion= De. Accessed: 09.07.2018. 30. Recombinant Human Trypsin [electronic resource]. URL: https://www.made-in-china.com/showroom/yaxinbio/productdetailrqpQzZOjMCWe/China-Recombinant-Human-Trypsin.html. Accessed: 08.07.20
(check this in PDF content)
11
Hegyi e., Sahin-Toth M. Genetic Risk in Chronic Pancreatitis: The Trypsin-Dependent Pathway. Dig. Dis. Sci. 2017; 62: 1692-1701. DOI: 10.1007/s10620-017-4601-3.
(check this in PDF content)
12
Németh B. C., Wartmann T., Halangk W., Sahin-Tóth M. Autoactivation of Mouse Trypsinogens Is Regulated by Chymotrypsin C via Cleavage of the Autolysis Loop. J. Biol. Chem. 2013; 288 (33): 24049-62. DOI: 10.1074/jbc.M113.478800.
(check this in PDF content)
13
Grishina Z., Ostrowska e., Halangk W., Sahin-Toth M., Reiser G. Activity of recombinant trypsin isoforms on human proteinaseactivated receptors (PAR): mesotrypsin cannot activate epithelial PAR1, -2, but weakly activates brain PAR-1. British J. Pharmacology. 2005;
(check this in PDF content)
14
990-999. 14. Yousef G. M., elliott M. B., Kopolovic A. D., Serry e., Diamandis e. P. Sequence and evolutionary analysis of the human trypsin subfamily of serine peptidases. Bioch. Bioph. Acta. 2004; 1698: 77-86.
(check this in PDF content)
15
Németh B. C., Sahin-Tóth M. Human cationic trypsinogen (PRSS1) variants and chronic pancreatitis. Am. J. Physiol. Gastrointest. Liver Phyiol. 2014; 306: G466-G473. DOI: 10.1152/ajpgi.00419.2013.
(check this in PDF content)
16
Hu C., Wen L., Deng L., Zhang C., Lugea A., Su H. Y., Waldron R. T., Pandol S. J., Xia Q. The Differential Role of Human Cationic Trypsinogen (PRSS1) p.R122H Mutation in Hereditary and Nonhereditary Chronic Pancreatitis: A Systematic Review and MetaAnalysis. Gastroenterol. Res. Pract. 2017; ID 9505460: 1-7. DOI: 10.1155/2017/9505460.
(check this in PDF content)
17
Roxas M. The Role of enzyme Supplementation in Digestive Disorders. Altern. Med. Rev. 2008; 13 (4): 307-314.
(check this in PDF content)
18
Ianiro G., Pecere S., Giorgio V., Gasbarrini A. and Cammarota G. Digestive enzyme Supplementation in Gastrointestinal Diseases. Current Drug Metabolism. 2016; 17 (2): 187-193.
(check this in PDF content)
19
Shah D., Mital K. The Role of Trypsin: Chymotrypsin in Tissue Repair. Adv. Ther. 2018; 35 (1): 31-42.
(check this in PDF content)
20
Konstan M. W., Frank J., Accurso F. J., Nasr S. Z., Ahrens R. C., Graff G. R. efficacy and safety of a unique enteric-coated bicarbonatebuffered pancreatic enzyme replacement therapy in children and adults with cystic fibrosis. Clin. Invest. 2013; 3 (8): 723-729.
(check this in PDF content)
21
Taylor C. J., Thieroff-ekerdt R., Shiff S., Magnus L., Fleming R., Gommoll C. Comparison of two pancreatic enzyme products for exocrine insufficiency in patients with cystic fibrosis. J. Cystic Fibrosis. 2016; 15: 675-680.
(check this in PDF content)
22
Petrides D. Bioprocess Design and economics. Bioseparations Science and engineering 2nd edition (ed by: Harrison R. G., Todd P. W., Rudge S. R., Petrides D. P.). Oxford University Press. 2015; 11.1-83.
(check this in PDF content)
23
Pan Y., Cheng K., Mao J., Liu F., Liu J., Ye M., Zou H. Quantitative proteomics reveals the kinetics of trypsin-catalyzed protein digestion. Anal. Bioanal. Chem. 2014; 406: 6247-6256.
(check this in PDF content)
24
Sarrouch B., Santos T. M., Miyoshi A., Dias R., Azevedo V. UpTo-Date Insight on Industrial enzymes Applications and Global Market. J. Bioproces. Biotechniq. 2012; (S4:002): 1-10.
(check this in PDF content)
25
Guidance for Industry exocrine Pancreatic Insufficiency Drug Products – Submitting NDAs U. S. Department of Health and Human Services Food and Drug Administration Center for Drug evaluation and Research (CDeR) April 2006 Clinical/Medical.
(check this in PDF content)
26
Global Recombinant Trypsin Solution Market Report 2018 by Manufacturer, Region, Type and Application, Forecast to 2023. [electronic resource]. URL: https://www.marketresearchstore.com/ report/global-recombinant-trypsin-solution-market-report-2018by-250199. Accessed: 09.07.2018.
(check this in PDF content)
27
Trypsin recombinant, Proteomics Grade. [electronic resource]. URL: https://www.sigmaaldrich.com/catalog/product/ Сведения об авторе: Пономаренко София Васильевна – руководитель проектов фирмы SophiGen в г. Бенен, Германия. Тел: (49) 23819411914. e-mail: ponomarenko@t-online.de. About the author:
(check this in PDF content)